European Union - English - EMA (European Medicines Agency)

warner chilcott uk ltd. - testosterone - sexual dysfunctions, psychological - sex hormones and modulators of the genital system, - intrinsa is indicated for the treatment of hypoactive sexual desire disorder (hsdd) in bilaterally oophorectomised and hysterectomised (surgically induced menopause) women receiving concomitant estrogen therapy.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

warner chilcott uk ltd - risedronate sodium - oral tablet - 30mg

Ireland - English - HPRA (Health Products Regulatory Authority)

warner chilcott uk limited - risedronate sodium ; calcium carbonate; colecalciferol - granules effervescent - 35 + 1000/880 iu milligram - risedronic acid, calcium and colecalciferol, sequential

Ireland - English - HPRA (Health Products Regulatory Authority)

warner chilcott uk limited - risedronate sodium - tablets gastro-resistant - 35 milligram - bisphosphonates

Ireland - English - HPRA (Health Products Regulatory Authority)

warner chilcott uk limited - risedronate sodium - film coated tablet - 35 milligram - bisphosphonates

Ireland - English - HPRA (Health Products Regulatory Authority)

warner chilcott uk limited - risedronate sodium - film coated tablet - 5 milligram - bisphosphonates

Ireland - English - HPRA (Health Products Regulatory Authority)

warner chilcott uk limited - risedronate sodium - film coated tablet - 30 milligram - bisphosphonates

Ireland - English - HPRA (Health Products Regulatory Authority)

warner chilcott uk limited - risedronate sodium - film coated tablet - 75 milligram - bisphosphonates

Ireland - English - HPRA (Health Products Regulatory Authority)

warner chilcott uk limited - risedronate sodium - film coated tablet - 75 milligram - bisphosphonates

Ireland - English - HPRA (Health Products Regulatory Authority)

warner chilcott uk limited - risedronate sodium - film coated tablet - 35 milligram - bisphosphonates